BioSpace News Archive

PMI BioPharma Solutions (https://pmibio.com/), a specialty CDMO providing Contract Research, Drug Discovery, Development and Manufacturing Services officially formed in January of 2018, announced that David Sunseri, PhD has been appointed Chief Executive Officer effective August 2018.

SurModics, Inc. (NASDAQ: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced today Teri Sides has joined Surmodics as Senior Vice President and Chief Marketing Officer, effective November 1, 2018.

Paperless validation enables life-transforming medicines at a faster pace to patients with serious diseases

Company presents first clinically viable therapy to address a cancer with no effective targeted treatment

Mr. Haydon will serve on the Executive Leadership Team and report to Jorgen B. Hansen, President and CEO.

All patients receiving Iomab-B therapy in both the study arm and those that crossed over from the control arm achieved engraftment following bone marrow transplant despite high bone marrow blast counts

Continues delivery momentum with sixth of ten advanced GPS III satellite navigation payloads

Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it will present one oral and two poster presentations related to its AUTO3 and AUTO5 programs at the 60th American Society of Hematology (ASH) Annual Meeting and Exposition

Phase 3 MEDALIST trial results to be presented in Plenary Scientific Session

DJO, a leading provider of medical technologies designed to get and keep people moving, introduced the EMPOWR Porous™ Knee System and EMPOWR™ Complex Primary Knee System at the 2018 Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS) today (Booth # 510).